ARICI, M. Et Al. 2024. The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials. FRONTIERS IN MEDICINE , vol.11 .

ARICI, M., ALTUN, B., Araz, M., Atmaca, A., DEMİR, T., Ecder, T., ... GÜZ, G.(2024). The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials. FRONTIERS IN MEDICINE , vol.11.

ARICI, MUSTAFA Et Al. "The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials," FRONTIERS IN MEDICINE , vol.11, 2024

ARICI, MUSTAFA Et Al. "The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials." FRONTIERS IN MEDICINE , vol.11, 2024

ARICI, M. Et Al. (2024) . "The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials." FRONTIERS IN MEDICINE , vol.11.

@article{article, author={MUSTAFA ARICI Et Al. }, title={The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials}, journal={FRONTIERS IN MEDICINE}, year=2024}